These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6719506)

  • 21. [Biochemical evaluation of damage due to lead: importance and significance of erythrocyte zinc-protoporhyrin IX and urinary amino acid determination].
    Sanguinetti F; Dompè M; Ronca G
    Ann Ist Super Sanita; 1977; 13(1-2):399-407. PubMed ID: 603137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastrointestinal symptoms in lead workers].
    Yoshida K; Sakurai H; Toyama T
    Sangyo Igaku; 1982 May; 24(3):229-35. PubMed ID: 7143795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemic changes in lead-exposed workers after onset of exposure.
    Yoshida K; Sakurai H
    Keio J Med; 1984 Apr; 33(1):29-38. PubMed ID: 6482141
    [No Abstract]   [Full Text] [Related]  

  • 24. Imported occupational lead poisoning: report of four cases.
    Petracca M; Scafa F; Boeri R; Flachi D; Candura SM
    Med Lav; 2013; 104(6):428-33. PubMed ID: 24640829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Abdominal disorders in lead poisoning].
    Liubchenko PN
    Sov Med; 1983; (5):79-83. PubMed ID: 6351279
    [No Abstract]   [Full Text] [Related]  

  • 26. Lead toxicity and heme biosynthesis.
    Lubran MM
    Ann Clin Lab Sci; 1980; 10(5):402-13. PubMed ID: 6999974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical and electrophysiological studies in subjects with occupational exposure to lead poisoning].
    Kazibutowska Z; Mierzwa P; Mierzwa E
    Neurol Neurochir Pol; 1979; 13(2):155-62. PubMed ID: 450179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lead levels in workers' blood and urine].
    Pavlovskaia NA
    Gig Sanit; 1990 Aug; (8):42-4. PubMed ID: 2283065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-dependent changes in lead and delta-aminolevulinic acid after subchronic lead exposure in rats.
    Kang HG; Jeong SH; Cho MR; Cho JH; Bischoff K
    Hum Exp Toxicol; 2009 Oct; 28(10):647-54. PubMed ID: 19755440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occupational exposure to inorganic compounds of lead. Investigation of -aminolevulinic acid and coproporphyrin excretion rates of persons exposed occupationally for the first time.
    Urbanowicz H
    Arch Environ Health; 1971 Oct; 23(4):284-8. PubMed ID: 5111310
    [No Abstract]   [Full Text] [Related]  

  • 31. [Porphyrin metabolism and hematologic diseases in lead poisoning].
    Cotrone D; Fiumi G
    Minerva Med; 1971 Mar; 62(20):1041-8. PubMed ID: 5551791
    [No Abstract]   [Full Text] [Related]  

  • 32. Excretion of porphyrins and porphyrin precursors during neuromuscular paralysis produced by dithiobiuret.
    Atchison WD; Peterson RE
    Exp Neurol; 1984 Jul; 85(1):63-8. PubMed ID: 6428932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
    Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
    Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of water restriction and water loading on urinary excretion of lead, delta-aminolevulinic acid and coproporphyrin.
    Araki S
    Br J Ind Med; 1978 Nov; 35(4):312-7. PubMed ID: 737138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of some parameters of lead exposure and possible correlation between them.
    Soliman MH; El-Sadek YM; El-Kashlan KM; Gabr Y; El-Waseef A
    J Egypt Med Assoc; 1976; 59(5-6):469-80. PubMed ID: 1032315
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental lead intoxication in dogs: a comparison of blood lead and urinary delta-aminolevulinic acid following intoxication and chelation therapy.
    Green RA; Selby LA; Zumwalt RW
    Can J Comp Med; 1978 Apr; 42(2):205-13. PubMed ID: 667707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy.
    Fritsch C; Batz J; Bolsen K; Schulte KW; Zumdick M; Ruzicka T; Goerz G
    Photochem Photobiol; 1997 Jul; 66(1):114-8. PubMed ID: 9230710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects of porphyrin measurement, other than lead poisoning.
    Lamon JM
    Clin Chem; 1977 Feb; 23(2 PT. 1):260-3. PubMed ID: 832389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of delta aminolevulinic acid in urine in a population exposed to lead].
    Molina-Ballesteros G; Zuñiga-Charles MA; Sanchez-Anzaldo FJ
    Arch Invest Med (Mex); 1976; 7(3):115-22. PubMed ID: 1015930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Species difference of urinary excretion of delta-aminolevulinic acid and coproporphyrin in mice and rats exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y
    Toxicol Lett; 1988 Jun; 41(3):255-9. PubMed ID: 3376152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.